# A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation

> **NCT00540787** · PHASE4 · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 112 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** Radiofrequency ablation, antiarrhythmic drugs
- **DRUG:** Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugs
- **DEVICE:** ThermoCool Radiofrequency Catheter

## Key facts

- **NCT ID:** NCT00540787
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08-01
- **Primary completion:** 2006-06-01
- **Final completion:** 2006-06-01
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00540787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00540787, "A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00540787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*